Steroids in relation to epilepsy and anaesthesia

Increasing numbers of reports indicate direct effects of ovarian steroids on the central nervous system. Effects of progesterone and its metabolites on brain excitability in humans and in experimental animals have been studied. Anti-epileptic effects have been shown in cats and in women with partial epilepsy and well-defined epileptic foci. The reduced progesterone metabolite 5 alpha-pregnan-3 alpha-ol-20-one and its 5 beta analogue also decreased the epileptic activity resulting from a penicillin-induced cortical focus in cats. 5 alpha-Pregnan-3 alpha-ol-20-one protected mice against metrazol-, bicuculline- and picrotoxin-induced seizures but not against electroshock-and strychnine-induced seizures. Progesterone, 5 alpha-pregnan-3 alpha-ol-20-one and 5 beta-pregnan-3 alpha-ol-20-one also induce anaesthesia in humans and animals; in a rat model of anaesthesia 5 alpha-pregnan-3 alpha-ol-20-one was eight times more potent than methohexitone (the most potent anaesthetic barbiturate). Anaesthesia with loss of the eyelash reflex was observed in humans 75-90 seconds after the intravenous injection of 5 beta-pregnan-3 alpha-ol-20-one in lipid emulsion. The in vivo production and brain distribution of centrally active steroids has also been studied in relation to the phases of the ovarian and menstrual cycle. A subset of women with epilepsy show changes in seizure frequency in relation to hormonal variations during the menstrual cycle. In the luteal phase when progesterone levels are high the number of generalized seizures is low. It is possible that progesterone and its metabolites play a role in epileptic seizures and also in the premenstrual syndrome.

Dynamic aspects of acute tolerance to allopregnanolone evaluated using anaesthesia threshold in male rats

BACKGROUND

It is unclear if allopregnanolone (AlloP) anaesthesia can induce tolerance. Acute tolerance is defined as altered sensitivity to a drug during a single continuous exposure.

METHODS

Induction of acute tolerance to AlloP was studied in male rats using a threshold technique of deep anaesthesia. AlloP was infused at a dose rate of 4.0 mg kg(-1) min(-1). The infusion was stopped when a burst suppression of 1 s or more (the "silent second", SS) occurred in the EEG. To maintain anaesthesia, the infusion was restarted when no SS had been seen in the EEG for 1 min. This interrupted targeted infusion towards an EEG end-point (SS) was continued until 30, 60 or 90 min of anaesthesia had been reached. At these times the rats were killed and AlloP concentrations in serum, muscle, fat and different brain regions were determined by radioimmunoassay.

RESULTS

Maintenance dose rate (MDR) was calculated using 20-min intervals. During anaesthesia the MDR increased (P<0.001) from 0.67 (sem 0.03) mg kg(-1) min(-1) (in the interval 10-30 min) to 0.98 (0.04) mg kg(-1) min(-1) (in the interval 65-85 min). After 60 min a slight increase in MDR was observed. After 90 min of anaesthesia the AlloP concentrations in the hippocampus and brainstem had increased by more than 50% compared with control values of 25.2 (1.13) and 52.7 (5.81) nmol g(-1) respectively, and after 60 min to around 40%. At 30 min no increase was seen in any brain region analysed.

CONCLUSIONS

Measurements in vivo and in vitro record acute tolerance to AlloP occurring with a delay.

Phytoplankton successions under ice cover in four lakes located in north-eastern Sweden: effects of liming

Phytoplankton successions under ice cover (January-March) were determined in four oligotrophic lakes (Burtjärn, Aspen, Vialamptjärn and Storkorstjärn) located in North-Eastern Sweden. The total phosphorus concentration in the lakes was less than 10 micrograms/L. Lake Burtjärn (reference lake) had a similar hydrology as Lake Aspen. Storkorstjärn and Vialamptjärn were of similar hydrology and had heavily colored water (> 100 mgpt/L). Aspen as well as vialamptjärn became continuously limed with calcium carbonate annually during the last decades. Biodiversity was considerably higher in the limed lakes (Aspen and Vialamptjärn) than in the untreated lakes (Burtjärn and Storkorstjärn). In Lake Burtjärn the most frequent species were Rhodomonas lacustris, Tabellaria flocculosa and Botryococcus braunii. Cryptophyceae (R. lacustris and Cryptomonas marssonii) and Dinophyceae (especially Gymnodinium lantzschii) were common phytoplankton groups in Lake Aspen. Tabellaria flocculosa was also the most common organism in both humic lakes Storkorstjärn and Vialamptjärn, other phytoplankton groups were in the humic lakes scarce. Liming was found to have profound effects on phytoplankton communities studied.

Neuroactive steroids and central nervous system disorders

Steroid hormones are vital for the cell life and affect a number of neuroendocrine and behavioral functions. In contrast to their endocrine actions, certain steroids have been shown to rapidly alter brain excitability and to produce behavioral effects within seconds to minutes. In this article we direct attention to this issue of neuroactive steroids by outlining several aspects of current interest in the field of steroid research. Recent advances in the neurobiology of neuroactive are described along with the impact of advances on drug design for central nervous system (CNS) disorders provoked by neuroactive steriods. The theme was selected in association with the clinical aspects and therapeutical potentials of the neuroactive steroids in CNS disorders. A wide range of topics relating to the neuroactive steroids are outlined, including steroid concentrations in the brain, premenstrual syndrome, estrogen and Alzheimer's disease, side effects of oral contraceptives, mental disorder in menopause, hormone replacement therapy, Catamenial epilepsy, and neuractive steroids in epilepsy treatment.

Twinfilin is required for actin-dependent developmental processes in Drosophila

The actin cytoskeleton is essential for cellular remodeling and many developmental and morphological processes. Twinfilin is a ubiquitous actin monomer-binding protein whose biological function has remained unclear. We discovered and cloned the Drosophila twinfilin homologue, and show that this protein is ubiquitously expressed in different tissues and developmental stages. A mutation in the twf gene leads to a number of developmental defects, including aberrant bristle morphology. This results from uncontrolled polymerization of actin filaments and misorientation of actin bundles in developing bristles. In wild-type bristles, twinfilin localizes diffusively to cytoplasm and to the ends of actin bundles, and may therefore be involved in localization of actin monomers in cells. We also show that twinfilin and the ADF/cofilin encoding gene twinstar interact genetically in bristle morphogenesis. These results demonstrate that the accurate regulation of size and dynamics of the actin monomer pool by twinfilin is essential for a number of actin-dependent developmental processes in multicellular eukaryotes.

The Drosophila VEGF receptor homolog is expressed in hemocytes

Several signalling pathways have been defined by studies of genes originally characterised in Drosophila. However, some mammalian signalling systems have so far escaped discovery in the fly. Here, we describe the identification and characterisation of fly homologs for the mammalian vascular endothelial growth factor/platelet derived growth factor (VEGF/PDGF) and the VEGF receptor. The Drosophila factor (DmVEGF-1) gene has two splice variants and is expressed during all stages, the signal distribution during embryogenesis being ubiquitous. The receptor (DmVEGFR) gene has several splice variants; the variations affecting only the extracellular domain. The most prominent form is expressed in cells of the embryonic haematopoietic cell lineage, starting in the mesodermal area of the head around stage 10 of embryogenesis. Expression persists in hemocytes as embryonic development proceeds and the cells migrate posteriorly. In a fly strain carrying a deletion uncovering the DmVEGFR gene, hemocytes are still present, but their migration is hampered and the hemocytes remain mainly in the anterior end close to their origin. These data suggest that the VEGF/PDGF signalling system may regulate the migration of the Drosophila embryonic haemocyte precursor cells.

Evaluation and comparison of the pharmacokinetic and pharmacodynamic properties of allopregnanolone and pregnanolone at induction of anaesthesia in the male rat

We have evaluated and compared the pharmacokinetic and pharmacodynamic properties of allopregnanolone and pregnanolone at induction of anaesthesia in male rats. A threshold method was used, and the first burst suppression period of 1 s or more in the EEG was selected as the end-point after fairly slow infusions. An optimal dose of 4.0 mg kg(-1) min(-1) was noted for both steroids. Brain concentrations were low at low infusion rates, indicating that acute tolerance was not occurring. Significant positive correlations were noted between dose rate and serum concentrations of allopregnanolone (r = 0.94, P<0.001) and pregnanolone (r = 0.88, P<0.001). Such correlations were also seen in striatum, cerebellum, cortex and muscle for both steroids (P<0.01). Despite changing infusion rates, the concentrations of both steroids in brainstem, hippocampus and fat remained stable. Because no correlation between infusion rate and steroid concentration was noted in the brainstem and hippocampus, these two brain areas may be regarded as primary sites of action for allopregnanolone and pregnanolone. Pregnanolone concentrations in the brainstem and hippocampus were significantly higher than those of allopregnanolone, suggesting that allopregnanolone was more potent than pregnanolone in inducing anaesthesia.

Inhibition of bacilli in industrial starches by nisin

The properties of Bacillus coagulans and of other bacilli that contaminate paper and paperboard manufacturing processes were investigated under simulated industrial conditions. Nisin (0.05 to 0.125 microg ml(-1) blocked growth of indigenous bacilli that contaminate sizing starches. B. coagulans starch isolates, B. licheniformis, B. amyloliquefaciens, and B. stearothermophilus grew at > or = 50 degrees C in industrial starch and produced alpha-glucosidase and cyclodextrins. The industrial isolates and reference strains of B. amyloliquefaciens, B. cereus, B. coagulans, B. flexus, B. licheniformis, B. pumilus, B. sporothermodurans, B. stearothermophilus and Alicyclobacillus acidoterrestris were inhibited by < or = 0.125 microg of nisin on agar. B. coagulans and B. stearothermophilus were similarly inhibited by < or = 0.025 microg of nisin ml(-1) and by 3 microg of the biocide DBNPA ml(-1) in industrial starch. B. licheniformis and B. amyloliquefaciens strains were less sensitive. About 40% of nisin added to starch was retained after cooking. Fifty percent of the nisin remained active after 11 h of storage at 60 degrees C. The results show that nisin has potential as a preservative for modified industrial starches.

Forced ethanol treatment stimulates and inhibits ethanol intake in a rat model of alcoholism

In a model of psychological dependence, a very stable ethanol intake was induced by a chronic (1-year) intermittent (once a week) exposure to intoxicating amounts of ethanol (24 h choice between ethanol and water, followed by 2.0 g/kg i.p.). After this year, the rats had continuous access to ethanol and water. Stability was shown by the ability of the rats to take the same dose of ethanol (in g/kg) when the concentration was changed from 10 to 20%. To study possible priming or inhibiting effects on ethanol intake, ethanol was injected i.p., first as 20%, 40% or 60% of the intake in the 24 h prior to the injection, then as fixed doses of 0.5, 1, and 2 g/kg, and the ethanol intake during the following 24-h period was recorded. The results showed that, following a low dose of ethanol, voluntary ethanol intake was increased in rats with a low, and decreased in rats with a high, ethanol intake, while high doses of ethanol seemed to decrease voluntary ethanol intake in all rats. The results are discussed in relation to theories about loss of control of drinking and relapse in humans.

Evidence for a mosaic structure of the Tn5481 in Lactococcus lactis N8

The sequences of the left end of the nisin-sucrose transposon Tn5481 in Lactococcus lactis subsp. lactis N8, the adjacent 1.5 kb chromosomal region upstream of the junction site as well as a 5.0 kb region downstream of the nisZBTCIPRKFEG genes within the transposon have been determined. In the upstream chromosomal region, an incomplete open reading frame encoding a protein with strong N-terminal homology to the low-affinity branched chain amino acid carriers was identified. Within the transposon, downstream of the nisin gene cluster, a 186 bp almost identical copy of the left hand sequence was located. Further downstream, four new open reading frames were found. The codon usage in these reading frames as well as the G+C content of the region are clearly different from those of the nisin genes, suggesting that the functionally unrelated areas of Tn5481 are gathered from different origins during the evolution of the transposon.

A nisin bioassay based on bioluminescence

A Lactococcus lactis subsp. lactis strain that can sense the bacteriocin nisin and transduce the signal into bioluminescence was constructed. By using this strain, a bioassay based on bioluminescence was developed for quantification of nisin, for detection of nisin in milk, and for identification of nisin-producing strains. As little as 0.0125 ng of nisin per ml was detected within 3 h by this bioluminescence assay. This detection limit was lower than in previously described methods.

Physical dependence after benzodiazepine treatments in rats: Comparison of short and long treatments with diazepam and lorazepam

OBJECTIVE

This study examined the development of physical dependence after different durations of treatments with two benzodiazepines (diazepam and lorazepam).

METHOD

Increased excitation in the central nervous system during a 2-week withdrawal period after 4-day and 4-week treatments with diazepam and lorazepam was examined with an EEG threshold method in male rats. Increased excitation was measured as a decreased sensitivity to hexobarbital (i.e., increased threshold doses). The concentrations of hexobarbital in two different brain regions, serum, fat and muscle tissue after 4-week treatment with diazepam were determined with a high-pressure liquid chromatography method.

RESULTS

The duration of withdrawal was influenced by the duration of treatment but the maximum level of withdrawal excitation was similar for both drugs. Equieffective doses of diazepam (20 mg/kg) and lorazepam (2 mg/kg) induced similar patterns of withdrawal excitability after both treatments. The brain concentrations of hexobarbital were significantly higher on Days 1 and 3 of withdrawal after diazepam treatment. Significant correlations between the threshold doses and brain concentrations were found on Day 1, but these correlations disappeared on day 3. At the same time, a difference between the concentrations of hexobarbital in different brain areas emerged.

CONCLUSIONS

The duration of treatment had a minor influence on the pattern of withdrawal excitation. Equieffective doses of diazepam and lorazepam induced comparable withdrawal excitability indicating no significant difference in their potential to induce physical dependence. The time-dependent change in the hexobarbital concentrations in the brain suggests that withdrawal excitation after diazepam treatment is a complex phenomenon probably involving several different systems at different times.

Acute and long term effects of buspirone treatments on voluntary ethanol intake in a rat model of alcoholism

Buspirone, a 5-HT1A agonist, has been shown to decrease the intake of ethanol when given as a single dose to rats with a psychological dependence induced according to our rat model of alcoholism. The present experiment evaluates the effects different treatments with buspirone have on voluntary ethanol intake in these psychologically dependent rats. As a first treatment, buspirone was given once daily for 23 days at the dose of 20 mg/kg/day. Ethanol was withheld except for the first and the last day of the treatment. On the first day, the buspirone injection decreased ethanol intake from the pretreatment value (1.94+/-0.18 g/kg/day), down to 1.36+/-0.18 g/kg (p < 0.01, n = 12). The rats were again given a choice between water and 10% ethanol after the last injection of buspirone. During the following 24 hr period, the ethanol intake was increased to 3.56+/-0.24 g/kg/day (p < 0.001 vs. the pretreatment intake, n = 12). A loss of correlation with the pretreatment intake of ethanol indicated an altered regulation of ethanol intake for approximately 3 more weeks. Fifteen weeks after the start of the first treatment, buspirone (20 mg/kg) was re-tested as a single dose, with no effect on ethanol intake. Twenty-two weeks after the start of the first treatment, a 1-week treatment with 20 mg/kg/day of buspirone was started. During this treatment, the rats had a continuous choice between 10% ethanol and water. There was, as in the first re-test, no effect on ethanol intake on the first day of the treatment. However, on the last 2 days of the treatment, the ethanol intake was increased to 2.86+/-0.28 g/kg and to 2.89+/-0.26 g/kg respectively (p < 0.05, n = 10 on both days, compared with the pretreatment intake of 1.78+/-0.36 g/kg). Thus, an acute dose of buspirone can decrease voluntary ethanol intake in psychologically dependent rats, but long-lasting changes in the effect of buspirone seem to develop during a 3-week treatment period.

Anaesthetic effects of pregnanolone in combination with allopregnanolone, thiopental, hexobarbital and flurazepam: an EEG study in the rat

The anaesthetic interactions of the steroid, 3 alpha-hydroxy-5 beta-pregnan-20-one, in male rats were investigated in different fixed binary combinations with the steroid allopregnanolone (3 alpha-hydroxy-5 alpha-pregnan-20-one), two barbiturates (thiopental and hexobarbital) and the benzodiazepine, flurazepam. Anaesthetic effects were determined using an EEG threshold method. Interactions were assessed using an isobolographic method. The interaction between the two steroids, pregnanolone and allopregnanolone, showed an anaesthetic effect significantly less than additive (antagonistic). The interactions between pregnanolone and the two barbiturates and the benzodiazepine showed an anaesthetic effect significantly greater than additive (potentiation) in all tests performed. These results could be explained by a pharmacodynamic interaction at the hypothetical GABA-benzodiazepine-barbiturate-steroid complex in the CNS.

Inhibition of anandamide hydrolysis by the enantiomers of ibuprofen, ketorolac, and flurbiprofen

The endogenous cannabimimetic anandamide is hydrolyzed by a fatty acid amide hydrolase to yield arachidonic acid and ethanolamine. In the present study, the regional distribution of the activity and its sensitivity to inhibition by the enantiomers of ibuprofen, ketorolac, and flurbiprofen has been investigated. The rate of [3H]anandamide hydrolysis was found in both 7-week-old and 90-week-old rats to be in the order hippocampus > cerebral cortex > cerebellum > striatum approximately midbrain, with higher rates of hydrolysis for the 7-week-old rats than for the 90-week-old rats. In whole brain (minus cerebellum), the R(-)-enantiomer of ibuprofen was a mixed-type inhibitor of anandamide hydrolysis and was approximately 2-3 times more potent than the S(+)-enantiomer, IC50 values of 230 and 750 microM, respectively, being found. A similar pattern of inhibition of anandamide hydrolysis was seen when intact C6 rat glioma cells were used. Ketorolac inhibited rat brain anandamide hydrolysis, with IC50 values of 50, 440, and 80 microM being found for the R-, S-, and R,S-forms, respectively. The IC50 value for R-flurbiprofen (60 microM) was similar to the IC50 value for the S-enantiomer (50 microM). These data demonstrate that there is no dramatic enantiomeric selectivity of NSAID compounds as inhibitors of fatty acid amide hydrolase enzyme(s) responsible for the hydrolysis of anandamide. The enantiomers of flurbiprofen and R-ketorolac are the most potent NSAID inhibitors of fatty acid amide hydrolase yet reported.

Citalopram as an inhibitor of voluntary ethanol intake in the male rat

Psychological dependence was induced in rats by a 1-year intermittent exposure to intoxicating doses of ethanol, and recorded by the rat's ability to later take the same dose of ethanol independent of the offered concentration. Citalopram (10 or 40 mg/kg/day) was given for 3 weeks with ethanol available only the first and the last day; 10 mg/kg had no effect. On the first treatment day 40 mg/kg decreased ethanol intake. On the last treatment day 40 mg/kg had no effect. The following week the ethanol intake was higher than before the treatment in the 40 mg/kg group. During the four posttreatment weeks the ethanol intake of the 40 mg/kg group dropped significantly. Citalopram was retested 18 weeks after the first treatment during 1 week, with continuous access to ethanol; 10 mg/kg had no effect and 40 mg/kg decreased ethanol intake at day 1, reaching a minimum in day 3. A tolerance to this effect was seen at the end of the week. Thus, in this model an acute dose of citalopram can decrease ethanol intake, but tolerance to this effect develops when citalopram is given both with and without access to ethanol.

The influence of age and administration rate on the brain sensitivity to propofol in rats

BACKGROUND

It is well established that the dose of propofol for induction of anaesthesia is influenced by patient age. This may be explained by differences in pharmacokinetics or pharmacodynamics. To evaluate the effect of age on propofol pharmacodynamics, the brain concentration of propofol at the time of an EEG end-point was used as a measure of CNS sensitivity.

METHODS

Ninety-five rats were assigned to 4 groups. Anaesthesia was induced by continuous propofol infusion at different rates. The dose of propofol and duration of anaesthesia were determined from 23 up to 776 days of age. The rats were killed at 23, 287 or 776 days of age at the EEG end-point and samples of cerebral cortex, midbrain, cerebellum, serum and fat tissue were submitted to HPLC analysis of propofol concentrations.

RESULTS

The induction dose of propofol varied with age and administration rate. Young animals needed a higher dose of propofol. Old animals had higher brain concentrations of propofol at the EEG end-point than young animals. However, propofol concentrations in serum were higher in young animals. The propofol concentration in the brain was influenced by the administration rate.

CONCLUSION

The dose of propofol for induction of anaesthesia in rats is influenced by animal age and administration rate. Young animals need a larger induction dose than old rats, but are more sensitive as measured by the brain concentration of propofol. The larger induction dose in young rats when compared with adults is explained by pharmacokinetic differences rather than by pharmacodynamic changes.

Development of physical dependence to lorazepam in rats: the effects of repeated short treatments, dose and age

Rats were treated with lorazepam for four days (six times 2 mg kg(-1)) at the ages of 71, 118, 163 and 210 days. Increased excitation (physical dependence) in the withdrawal period was tested several times during 14 days with hexobarbital in an EEG threshold test. Lorazepam could induce physical dependence usually with a maximum (20% of the controls) on day four of withdrawal, but the age was a critical variable. A dose-response relationship with regard to lorazepam (0.5, 1, 2 mg kg(-1)) was found at 71 days but a more complicated pattern was found at 118 days of age. The rats treated with lorazepam 2 mg kg(-1) at the ages of either 71 and 118 days were given a treatment again with lorazepam 2 mg kg(-1) three months later. Compared with age-matched untreated rats, previous drug exposure influenced the pattern of increased excitation indicating a carry-over effect even after such a recovery period.

The effect of diazepam on voluntary ethanol intake in a rat model of alcoholism

This paper reports the effects of a diazepam treatment on voluntary ethanol intake in rats included in an animal model of alcoholism. In a first dose-seeking experiment, rats had a choice between 10% (w/v) ethanol and water for 24 h each week. Single doses of diazepam between 2 and 20 mg/kg injected i.p. prior to the 24-h choice caused a dose-dependent decrease in voluntary ethanol intake from 3.2 +/- 0.4 g/kg/day down to 2.3 +/- 0.3 g/kg/day (P < 0.01) after a dose of 20 mg/kg. In a second experiment, psychological dependence was induced by a 1-year intermittent exposure to ethanol (a choice between 10% ethanol and water for 24 h each week, followed by an i.p. injection of 2.0 g/kg of ethanol). After this year, the rats were given a continuous choice between ethanol and water. A 3-week treatment with diazepam (20 mg/kg/day, i.p.) was started in week 68, during which period a choice of 10% (w/v) ethanol was available only on the first and the last days of treatment. On the first day of the diazepam treatment, ethanol intake was decreased from a pre-experimental value of 2.7 +/- 0.3 g/kg/day to 1.2 +/- 0.1 g/kg/day (P < 0.001). On the last day of the treatment, voluntary intake was higher than before the treatment (3.8 +/- 0.27 g/kg/day, P < 0.01). Ethanol intake remained elevated during the week after the end of the diazepam treatment (P < 0.05). When single doses of diazepam (20 mg/kg) were re-tested 10 and 19 weeks after the treatment, there was no decrease in ethanol intake, indicating that the initial effect had not been re-established.

Age-dependent changes in adenosine receptors are not modified by life-long intermittent alcohol administration

Autoradiography and in situ hybridisation were used to examine age-dependent changes in adenosine receptors in male rats and to determine if life-long (94 weeks) intermittent ethanol consumption had any additional effect. Adenosine A2A receptors in striatum, as assessed by [3H]CGS 21680 binding, decreased by approximately 20% between the ages 6 and 99 weeks. Since dopamine D2 receptors and the mRNA for preproenkephalin also decreased there appears to be a loss of A2A-D2 receptor-bearing striatopallidal cells. Life-long ethanol consumption had no additional effect. Adenosine A1 receptors, as determined by [3H]DPCPX binding, did not decrease with age in any region of the brain, but increased slightly in the cerebellum. In substantia nigra, the increase in [3H]DPCPX binding upon addition of GTP was eliminated. Surprisingly, the amount of A1 receptor mRNA decreased significantly with age in most of the examined regions, including the cerebellum. There was no additional effect of ethanol treatment. It is suggested that age alters the number of cells that express A2A receptors, the turnover of A1 receptors, and in some regions their coupling to G proteins, but that life-long intermittent ethanol exposure has little additional effect.

A study of the duration of acute tolerance induced with hexobarbital in male rats

Male rats were infused i.v. with hexobarbital to obtain a burst suppression of 1 s or more in the EEG (SS). At SS the rats were killed and the concentration of hexobarbital was determined by HPLC in three parts of the brain. Acute tolerance (induced by a 1-h exposure at the SS level) was recorded as an approximately 20% increase in brain concentrations of hexobarbital at the last SS during the exposure when compared with concentrations recorded at the first SS in the controls. Increased brain concentrations (approximately 8%) at SS were recorded 24 h after induction of acute tolerance. After 48 h the increase was uncertain. Thus, acute tolerance to hexobarbital could have cumulative properties if new exposures are imposed after 24 h.

The EEG burst suppression threshold test for the determination of CNS sensitivity to intravenous anesthetics in rats

The electroencephalographic (EEG) threshold test was developed to determine the central nervous system (CNS) sensitivity to several depressant drugs, mainly intravenous anesthetic agents. Test drugs were administered to the rats by continuous intravenous infusion until a defined EEG criterion indicating deep anesthesia was reached. The criterion was a burst suppression which lasted 1 s or more, the 'silent second' (SS). The dose of the drug needed to induce the SS, the threshold dose, was the dependent variable. In the intact animal, it is influenced by the potency of the drug and dose administration rate of the infusion (mg/kg/min). The method has several advantages over the commonly used anesthesia times (misnomer: sleeping time) where the duration is influenced by several pharmacokinetic properties such as metabolism and redistribution. With the method it is possible under in vivo conditions to monitor continuously the electrical changes in the CNS. No interruptions are necessary. The pharmacological end-point is well defined, easy to monitor and detect. The threshold doses of the drugs applied remained stable with repetitive testing of the same individual. Thus, it can be used effectively to determine the CNS sensitivity to a number of drugs and to follow changes in this sensitivity after several physiological, pharmacological or pathological interventions.

The regional brain distribution of the neurosteroids pregnenolone and pregnenolone sulfate following intravenous infusion

We have studied the distribution of the neurosteroids pregnenolone (Pe) and pregnenolone sulfate (PeS) in seven brain regions, and plasma and fat tissues in male adult rats following the intravenous infusion of 14 mg/kg Pe and 18 mg/kg PeS, respectively. After chromatographic separation of steroid sulfate esters and non-conjugated steroids by solid phase octadecyl C18 columns and celite column chromatographic separation of Pe from cross-reacted steroids, the concentrations of Pe and PeS were determined by radioimmunoassay. We found that both Pe and PeS concentrations were significantly increased in plasma, fat and brain compared to the vehicle controls after i.v. infusion of Pe and PeS. In the controls, Pe concentrations were highly correlated within brain regions and between fat and brain regions. Most correlations were lost after Pe and PeS infusions. The content of Pe and PeS was not uniformly distributed in the brain. The hypothalamus contained the highest level of Pe in controls, Pe-infused and PeS-infused rats (12 +/- 3.1, 3500 +/- 180 and 590 +/- 54 ng/g, respectively). The highest concentration of PeS was detected in the hypothalamus (26 +/- 8.2 ng/g) and striatum (17 +/- 4.1 ng/g) in controls, in the hypothalamus (200 +/- 24 ng/g) after PeS infusion as well as in the hypothalamus and medulla oblongata (57 +/- 9.6 and 55 +/- 7.6 ng/g, respectively) after Pe infusion. This study has yielded evidence that PeS injected i.v. can cross the blood-brain barrier without being hydrolysed to the more lipophilic Pe, and can thus be taken up by the brain.

Pregnenolone sulphate and pregnenolone do not interact with 5 beta-pregnanolone- and hexobarbitone-induced anaesthesia in the rat

We have studied the interaction of pregnenolone sulphate and pregnenolone with 5 beta-pregnanolone- and hexobarbitone-induced anaesthesia in male rats using an EEG threshold method. Burst suppression of the EEG of 1 s or more ("silent second" (SS)), was used as a criterion of deep anaesthesia. The effects of the steroid solvents albumin and beta-cyclodextrin were assessed by dose-response curves. Despite a significant increase in hexobarbitone threshold dose in relation to increased doses of albumin, there was no correlation between albumin dose and hexobarbitone concentrations in serum, fat and brain tissues. There was no significant difference in threshold concentrations of hexobarbitone between controls given albumin and those pretreated with pregnenolone. In subsequent experiments, 20% beta-cyclodextrin was used as steroid solvent and its volume was maintained at less than 3.0 ml kg-1 during pretreatment. Neither pregnenolone sulphate nor pregnenolone significantly altered the potency of 5 beta-pregnanolone for induction of anaesthesia. Furthermore, there was no interaction of pregnenolone sulphate and pregnenolone on induction of anaesthesia when hexobarbitone was used for anaesthesia.

Age-dependent development of acute tolerance to propofol and its distribution in a pharmacokinetic compartment-independent rat model

BACKGROUND

Previous animal and clinical studies have shown a dose-dependent increase in propofol concentrations in blood at wakening after propofol infusion. A development of an acute tolerance to propofol has been proposed. To elucidate this, brain concentrations of propofol at the time of an EEG end point was used as a measure of CNS sensitivity.

METHODS

Twenty young or 20 old rats were assigned to either induction of anaesthesia with propofol or induction followed by maintenance of anaesthesia with intermittent propofol infusions during 60 minutes. All rats were killed at the EEG end point and samples of cerebral cortex, hippocampus, striatum, brain stem, cerebellum, blood, muscle and fat tissue were submitted to HPLC analysis of propofol concentrations. A new model describing the infusion requirements is introduced.

RESULTS

The estimated infusion rate during maintenance declined exponentially with time at a slower rate in young compared with old rats. Old rats had higher propofol concentrations in blood, hippocampus, striatum, brain stem, cerebellum, muscle and fat after 60 minutes compared with induction. In contrast, young animals had no significant change in brain concentrations, but the propofol concentrations in muscle and fat were increased.

CONCLUSION

It is concluded that maintenance of propofol anaesthesia may alter the CNS sensitivity to propofol in old animals, i.e. an acute tolerance may develop. Young animals do not seem to be capable of developing an acute tolerance to propofol. The results also support previous findings that a redistribution is important for the rapid clearance of propofol from blood.

Buspirone as an inhibitor of voluntary ethanol intake in male rats

The effect of buspirone, a drug with mainly 5-HT1A-agonist activity, on voluntary ethanol intake was tested in a rat model of alcoholism. In this model the treatment consists of an injection of ethanol (2.0 g/kg) or saline once a week, preceded by a 24 h choice between water and ethanol (10% w/v). This weekly injection of ethanol reduces voluntary ethanol intake in male rats. Maximal inhibition is seen after 5-6 weeks. At this maximal inhibition buspirone or saline was injected prior to the voluntary 24 h intake of ethanol in both the ethanol- and saline-injected groups. The tested doses were 5 mg/kg (week 5) and 20 mg/kg (week 6). There was no reduction in ethanol intake in the buspirone-injected groups when compared with their corresponding controls. A second experiment with buspirone was performed during the evaluation period following treatment with ethanol. This treatment consisted of a choice between water and ethanol (10%, w/v) for 1 day each week, followed by an injection of ethanol 2.0 g/kg) and lasted for 52 weeks. During the evaluation period the rats had a continuous choice between ethanol and water for 37 weeks and no injections were given. In this situation, with a longer exposure to ethanol, a dose of 20 mg/kg of buspirone in week 90 reduced ethanol intake by approximately 40%, when compared with controls. The effect of this buspirone dose lasted at least a week. This indicates that the long-term exposure to ethanol in the second experiment induces changes that affect the serotonergic transmission, and that this changed neural system is involved in the regulation of voluntary ethanol intake.

Effects of TRH and atropine on induction and duration of anesthesia with propofol in rats

The effects of IV TRH pretreatment on induction of anesthesia with propofol or pentobarbital were investigated in rats. The effects of IV TRH, administered after induction, on duration of propofol anesthesia and the interaction with atropine were also studied. The doses of propofol or pentobarbital were not influenced by TRH. TRH reduced duration of anesthesia after propofol, with higher brain concentrations of propofol at recovery. Atropine did not block this effect, but given alone prolonged duration of anesthesia. It is concluded that TRH shortens the duration of propofol anesthesia, probably due to a pharmacodynamic effect and not to a pharmacokinetic interaction.

Potency of lipid and protein formulation of 5 alpha-pregnanolone at induction of anaesthesia and the corresponding regional brain distribution

We have studied the anaesthetic potencies of 5 alpha-pregnanolone albumin solution (PAS) and 5 alpha-pregnanolone Intralipid emulsion (PLE) at equivalent concentrations in male rats using an EEG threshold method. The criterion of anaesthesia was burst suppression of the EEG of 1 s or more (the "silent second" (SS)) as a sign of deep anaesthesia. The potency of the two formulations was assessed by comparing the threshold doses of 5 alpha-pregnanolone at three dose rates (1.0, 2.0 and 3.0 mg kg-1 min-1). We found that SS was initiated in all rats after infusions of PAS, while no SS could be induced in rats after infusion of PLE at a larger dose. A higher concentration of 5 alpha-pregnanolone was found in all brain and peripheral tissues of PAS-treated rats than in those treated with PLE. In rats with PAS-induced anaesthesia (3.0 mg kg-1 min-1), the highest concentrations were detected in striatum (mean 19.40 (SD 1.21) ng mg-1). Although there was a small insignificant reduction in threshold doses with dose rates at 2.0-3.0 mg kg-1 min-1, the tissue concentrations in striatum, frontal cortex and occipital cortex were found to be significantly increased. We conclude that PAS was more potent than PLE in inducing anaesthesia. Brain distribution of 5 alpha-pregnanolone varied regionally in a manner similar to the variation in GABAA receptor sensitivity to this neuroactive steroid.

Interaction between flumazenil and the anesthetic effects of hexobarbital in the rat

Interaction between flumazenil, a substance regarded mainly as a benzodiazepine antagonist, and an intravenous anesthetic barbiturate, hexobarbital, was investigated by using an electroencephalography threshold test in male rats. Flumazenil 10 mg/kg given as pretreatment reduced the threshold dose of hexobarbital approximately 20% indicating a synergistic interaction. Similar effects were obtained with the agonists, diazepam 20 mg/kg and lorazepam 2 mg/kg. Dose-response curve for flumazenil (2.5-10 mg/kg) was determined with the same technique and hexobarbital concentrations were analysed in serum and several brain regions at the threshold by high pressure liquid chromatography. Flumazenil 10 mg/kg pretreated group showed a different pattern of distribution of hexobarbital into the tested brain regions indicating a pharmacokinetic interaction. Low concentrations of hexobarbital in the brainstem which were negatively correlated with the dose of flumazenil indicate a pharmacodynamic interaction which could be due to partial agonistic intrinsic activity of flumazenil, usually seen at much higher doses.

Optimum rate of administration of propofol for induction of anaesthesia in rats

Twenty rats received propofol 2.5, 5, 10 or 20 mg kg-1 min-1 i.v. Brain activity was monitored using the electroencephalogram (EEG). As the endpoint for induction of anaesthesia we used a burst suppression period of 1 s or longer. At a fast (20 mg kg-1 min-1) rate of administration, the induction dose was significantly larger compared with a slower rate (10 mg kg-1 min-1). At a slow rate of administration (2.5 mg kg-1 min-1), the induction dose was also significantly larger compared with a rate of 10 mg kg-1 min-1. In spite of different dose requirements at different rates of administration, duration of anaesthesia was not significantly different.

Cholecystokinin receptor binding after long-term ethanol treatment in rats

Brain cholecystokinin (CCK) receptors have been implicated in anxiety disorders and suicidal behaviour. We have examined the radioligand binding ability of CCK and benzodiazepine receptors in rat brain after long-term intermittent voluntary vs voluntary and forced low-dose ethanol exposure. During 58 weeks, one group of rats had a choice between ethanol and water as the drinking fluid for 24 hr each week. Another group of rats had the same weekly choice between ethanol and water, but at the end of each 24 hr choice period, ethanol (2.0 g/kg) was injected. During the second period of ethanol treatment, lasting for 32 weeks, both ethanol-treated groups had continuous free access to ethanol and water. These two treatments have previously been shown to induce partially different neurochemical alterations. In the present investigation, benzodiazepine receptor binding in the frontal cortex, hippocampus and striatum was similar in both ethanol treatment groups compared to controls. CCK receptor binding in the hippocampus and striatum did not differ between the three groups; however, in the frontal cortex, there was an increase in the apparent number of CCK binding sites in the group of rats submitted to voluntary plus forced ethanol exposure as compared to the control group or the voluntary intake group. These results suggest that long-term ethanol treatment may lead to alterations in brain CCK-ergic neurotransmission, but that the changes are specific to the treatment schedule.

Recovery after interrupted exposure during induction of experimental alcoholism in the rat

A model of alcoholism founded on a long-term treatment with intermittent weekly ethanol exposures [each week a voluntary choice between 10% (w/v) ethanol and water for 24 hr followed by an intraperitoneal (i.p.) injection of 2.0 g/kg ethanol] was used to test the effect of a 10-week interruption of the treatment. Three groups were tested. Group CT had 65 weeks of treatment with no interruption. Group BT started the treatment at the same time as group CT, but no treatment was given in weeks 33-42. In group LS, the treatment started as the same time as it was restarted in group BT (week 43). An evaluation period with a continuous choice between ethanol and water was started in week 66. During the evaluation period dependence, defined as a voluntary ethanol intake not influenced by changes in ethanol concentration, was determined by comparing the intake of a 10% (w/v) reference solution with that of a 5% (w/v) test solution. At the start of the treatment the 24 hr voluntary ethanol intake in group CT and BT was inhibited maximally after 6-7 weeks of treatment. When group LS was started in week 43, a similar, but more marked, inhibition developed. In all groups, ethanol intake rose again after the inhibition. After restarting the treatment in group BT, the rats could be divided into two subgroups. Group BT;LI with a low intake of ethanol in week 32 had voluntary ethanol intake after restarting the treatment which was similar to corresponding data recorded in group LS when starting the treatment.(ABSTRACT TRUNCATED AT 250 WORDS)

Increase in brain GABA-transaminase activity after chronic ethanol treatment in rats

The activity of gamma-aminobutyrate aminotransferase (GABA-T) was measured in the brains of rats treated both acutely and sub-chronically with ethanol. Previously, chronic treatment with ethanol for 90 weeks was found to increase the mean brain GABA-T activity by 20-45%. In the present study acute ethanol treatment (4 g/kg, i.p.) did not induce and change in the activity of brain GABA-T with the exception of a small increase in the cerebellum (8%) and, after repeated treatment with ethanol (4 g/kg/day, i.p.) for one and two weeks, no change in the activity of GABA-T was also found in any of the brain regions examined. Subchronic treatment with ethanol for 14 weeks, performed according to two different schedules involving a voluntary intake of ethanol in the drinking water, resulted in approximately a two-fold difference in ethanol intake. A mean increase of 50-85% in the activity of GABA-T was found in all the brain regions of rats with higher ethanol intake in comparison with the group of rats with lower ethanol intake. A bimodal distribution of brain GABA-T activity, however, was found in the ethanol-treated rats, with 60% of the rats having a two-fold increase and the remaining 40% having unchanged activities. The addition of pyridoxal phosphate to the incubation media increased the activity of brain mitochondria from ethanol-treated rats with high brain GABA-T, whereas there was a decrease in the activity in control rats and in ethanol-treated rats in which no increase in brain GABA-T had occurred. These results show firstly, that in a subpopulation of rats, subchronically treated with ethanol for 14 weeks, there was a two-fold increase in brain GABA-T activity, while in another subgroup no change occurred, and, secondly, that this increase in GABA-T activity was a consequence of a change in the response of the apoprotein to the addition of the cofactor pyridoxal phosphate.

Brain GABA-transaminase and monoamine oxidase after chronic ethanol treatment in rats

The activities of gamma-aminobutyrate aminotransferase (GABA-T) and monoamine oxidase (MAO-A and -B) were estimated in various brain regions of rats exposed to ethanol for 90 weeks. During the first period (weeks 1-58), the rats had access to both ethanol (10% w/v) and water during a 24-hr interval at the end of each week. At this point, the animals were given either a saline injection (intraperitoneally, group 1) or an ethanol injection (2.0 g/kg ip, group 2). During the second period (weeks 59-90), the rats in groups 1 and 2 had continuous access to both ethanol and water. The third group was composed of untreated control rats. Compared with controls, there was an increase of 20-45% in the mean brain GABA-T activity in both groups of ethanol-treated rats. However, analysis of the data for the individual ethanol-treated rats revealed a considerable difference in brain GABA-T activity. Thus, approximately 30% of the ethanol-treated rats showed approximately twice the activity of rats in the exposed groups and in the control group. There was no connection between ethanol intake, water intake, or body weight and GABA-T activity in any of the brain regions examined. There was no effect of ethanol in vitro on the activity of GABA-T in the brain cortex in concentrations of 20-100 mM, whereas acetaldehyde inhibited the activity by 15% at these concentrations. The present results suggest that there is a bimodal distribution with respect to the effect of ethanol on rat brain GABA-T activity.(ABSTRACT TRUNCATED AT 250 WORDS)

Tolerance to hexobarbital induced by short-term treatments with diazepam and tested with an EEG-threshold test in male rats

Male Mol: SPRD rats were treated with 5 or 20 mg/kg of diazepam for 4 days. The treatment was repeated at two different ages. Diazepam was either dissolved in Intralipid (KABI, Sweden) or dispersed in gummi arabicum. Tolerance induced by the treatment was tested with an EEG-threshold technique where hexobarbital was infused intravenously on day 1, 4, 7 and 14 of the abstinence. The threshold was the dose of hexobarbital needed to induce a burst suppression of 1 sec. or more (silent second). After the first diazepam treatment significant increase in the hexobarbital threshold doses were recorded in all but one of the diazepam treated groups. The pattern varied depending on dose, age and solvent. After the second treatment tolerance was seen only when diazepam had been dissolved in Intralipid. Short term treatment with diazepam can induce cross-tolerance to hexobarbital which probably is due to an increased excitation (physical dependence) in abstinence after treatment with diazepam.

Maturation-related changes in tolerance development to hexobarbital after short term treatment with diazepam in the rat

Male rats at six different ages received diazepam on a 4-day treatment schedule. Cross-tolerance to hexobarbital was tested several times during withdrawal period with an anaesthesia threshold technique. Pattern of cross-tolerance was different at different ages. Thus, age and maturation of the rat is a variable which must be considered in studies of tolerance to diazepam.

Cholinergic mechanisms in physical dependence on barbiturates, ethanol and benzodiazepines

The aim of this review is to summarize the effects of acute and chronic treatment with barbiturates, ethanol and benzodiazepines on cholinergic mechanisms in the brains of experimental animals. A single dose of each of these substances reduces the turnover of ACh in the brain. Long-term treatment has the opposite effect; complicated interactions including decreased content of ACh are induced. Barbiturates have been shown to bind stereospecifically to muscarinic and nicotinic receptors in the brain, but this has not been observed for ethanol or the benzodiazepines. The effects on the cholinergic system are affected by the length of treatment and choice of treatment regimen. No effect on cholinergic parameters, such as muscarinic receptors, in the brain is observed on withdrawal of ethanol or barbiturate treatment when the animals are still tolerant towards the substances. The increase in the number of muscarinic receptors observed in several brain regions on withdrawal is seen as a sign of cholinergic supersensitivity. The number of receptors returns to normal when abstinence convulsions have occurred. The assumption of a cholinergic influence is supported by the finding that atropine, given as a single dose on the day of withdrawal of barbital, can prevent the muscarinic receptor changes. Furthermore, long-term barbital or ethanol treatment can induce permanent persistent changes in the cholinergic system in the brain. Cognitive defects and a significant permanent reduction in the content of ACh can be measured in rats which have had long-term barbital treatment. Similarly, a reduced number of muscarinic receptors has been measured in different brain regions of chronic alcoholics. Accumulating data support the role of the cholinergic system in expressing symptoms of physical dependence on barbiturates, ethanol and benzodiazepines as well as in the permanent long-term effects observed after end of treatment.